330 related articles for article (PubMed ID: 1202608)
1. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
2. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
Sheĭtanov I; Nikolov K; Petrova P
Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
[TBL] [Abstract][Full Text] [Related]
3. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
Nydegger UE; Zubler RH; Gabay R; Joliat G; Karagevrekis CH; Lambert PH; Miescher PA
J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
[TBL] [Abstract][Full Text] [Related]
4. Breakdown products of C 3 in human synovial fluids.
Zvaifler NJ
J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
[TBL] [Abstract][Full Text] [Related]
5. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.
Zubler RH; Nydegger U; Perrin LH; Fehr K; McCormick J; Lambert PH; Miescher PA
J Clin Invest; 1976 May; 57(5):1308-19. PubMed ID: 944196
[TBL] [Abstract][Full Text] [Related]
6. Activation of complement components C3 and factor B in synovial fluids.
Hunder GG; McDuffie FC; Mullen BJ
J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
[TBL] [Abstract][Full Text] [Related]
7. [Complement in rheumatoid articular inflammation].
Boloşiu HD; Duţu A; Duţu D; Duma V; Gligore V
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1975; 27(6):469-74. PubMed ID: 3842
[No Abstract] [Full Text] [Related]
8. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
Stojan B
Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
[TBL] [Abstract][Full Text] [Related]
9. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
[TBL] [Abstract][Full Text] [Related]
11. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
Naama JK; Mitchell WS; Whaley K
Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
[TBL] [Abstract][Full Text] [Related]
13. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
Stojan B
Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
[TBL] [Abstract][Full Text] [Related]
14. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
[TBL] [Abstract][Full Text] [Related]
15. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
[TBL] [Abstract][Full Text] [Related]
16. Immune complexes and complement in rheumatoid arthritis.
Lambert PH; Casali P; Nydegger U
Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):301-15. PubMed ID: 534786
[TBL] [Abstract][Full Text] [Related]
17. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
Perrin LH; Shiraishi S; Stroud RM; Lambert PH
J Immunol; 1975 Jul; 115(1):32-5. PubMed ID: 1171140
[TBL] [Abstract][Full Text] [Related]
18. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of classical complement pathway activation in rheumatoid arthritis: measurement of C1q-C4 complexes as novel activation products.
Wouters D; Voskuyl AE; Molenaar ET; Dijkmans BA; Hack CE
Arthritis Rheum; 2006 Apr; 54(4):1143-50. PubMed ID: 16572449
[TBL] [Abstract][Full Text] [Related]
20. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
